1058.80↑-3.65 (-0.34%)
03:49 PM,30th Nov 20231059.00↑5.75 (0.55%)
04:01 PM,30th Nov 2023BSE : 524075
NSE : ALBERTDAVD
Sector : Health care
ISIN Code : INE155C01010
Last Updated: Nov 30 2023 | 04:01 PM IST
Market Cap (₹ Cr) | 604 |
Turnover (₹ Cr) | 0.37 |
Volume (Shares) | 34954 |
Face Value | 10 |
52-WK High | 1092.00 |
52-WK High Date | 29 Nov 2023 |
52-WK Low | 505.95 |
52-WK Low Date | 31 Mar 2023 |
All Time High | 1092.00 |
All Time High Date | 29 Nov 2023 |
All Time Low | 263.00 |
All Time Low Date | 23 Mar 2020 |
Incorporated in 1938 at Calcutta Albert David (ADL) is headed by Chairman A K Kothari. Its units at Calcutta Ghaziabad and Raisin manufacture pharmaceutical formulations including amino acid infusions. The company also manufactures disposable syringes and needles and a wide range of bulk drugs. It is recognised as a large IV fluid manufacturer both in glass and polyethylene containers.ADL has entered into a technical collaboration with Morishita Pharmaceuticals Japan a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions for which it came out with a rights issue in Aug.'87. It has also set up a new unit in Kalyani West Bengal to manufacture bulk drugs which went on stream in 1990. Another rights issue in Mar.'90 augmented the long-term working capital. ADL has entered into technical collaboration with Pharma Plan Germany to supply machinery to manufacture 30 mln disposable syringes and 70 mln needles at Mandideep near Bhopal. ADL came up with a Rs 4.68-cr right issue to part finance the expansion of its capacity of IV fluids in plastic bottles (FFS technology) at Ghaziabad.During 1998-99 the company has developed some new products viz. Siozole Capsules and Ferrochelate-Z-Capsules with Iron & Zinc and folic acid in sustained released formulation. In 2002-03 the company has launched new products-INTECARNIMERIL-TEVICTALROF-50. It is also planning to launch new products such as SIOOXYALAMIN FEZPANSURE.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 604 |
EPS - TTM (₹) [S] | 101.70 |
P/E Ratio (X) [S] | 1.73 |
Face Value (₹) | 10 |
Latest Dividend (%) | 90.00 |
Latest Dividend Date | 03 Aug 2023 |
Dividend Yield (%) | 0.85 |
Book Value Share (₹) [S] | 613.47 |
P/B Ratio (₹) [S] | 1.73 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|---|---|---|
Motilal Oswal S&P BSE Healthcare ETF | 0.00 | 23 | 0.02 |
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 1030.65 1074.95 |
Week Low/High | 923.95 1092.00 |
Month Low/High | 813.70 1092.00 |
Year Low/High | 505.95 1092.00 |
All time Low/High | 3.15 1092.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 11.03% | 10.96% | 1.47 | 1.67% |
1 Month | 27.37% | 27.47% | 4.49 | 5.18% |
3 Month | 32.91% | 33.07% | 2.92 | 4.06% |
6 Month | 81.12% | 81.83% | 6.38 | 8.05% |
1 Year | 72.53% | 72.75% | 6.16 | 7.33% |
3 Year | 129.62% | 129.58% | 51.73 | 55.24% |
Executive Chairman : A K Kothari
Independent Director : Hemal Kampani
Independent Director : Rajiv Singhi
Director : Prabhawati Devi Kothari
Independent Director : Arindam Sarkar
Independent Director : Shirish Gundopant Belapure
Independent Director : Monjori Mitra
Director : Anand Vardhan Kothari
Company Sec. & Compli. Officer : A B Chakrabarty
Managing Director & CEO : U. M. Kunte
Registered Office: D Block 3rd Flr Gillander Hous, Netaji Subhas Road,Kolkata,West Bengal-700001 Ph: 91-33-22302330/2262 8436/8456/
Email:adidavid@dataone.in